< Back to Results
Primary Contact Name
Nirali Shah
Primary Contact Email Address
nirali.shah@nih.gov
Primary Contact Phone Number
2407606199
Program Name
NCI/Pediatric Oncology Branch Immunotherapy Fellowship
Address
9000 Rockville Pike
Bldg 10CRC, 1W-3750
Bethesda, MD, 20892
Program Director/Fellowship Director
Nirali Shah
Program Director/Fellowship Director Email
nirali.shah@nih.gov
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
CT
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
Yes
Is the primary focus of your program on adult or pediatric populations?
Adult, Pediatric
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
August
When does your Fellowship application period end?
March
Interview Format
Flexible
How many training spaces?
One
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
June, July, August
If flexible, please describe
Not Provided
If you selected yes, please specify the type of visa
Not Provided
What are the requirements for fellows applying to your program?
Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible)
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
Trainees will be able to have the experience rotating with both adult and pediatric cell therapy providers, across a host of diseases and adoptive cell therapy programs. They will also rotate through the Center for Cellular Engineering to learn more about the manufacturing platforms and how they are applied/utilized in generation of clinical products. They will also be able to engage in discussions surrounding the translation of bench to bedside therapeutics and the study of biologic correlatives which emerge from clinical trials.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
Not Provided
Allogeneic Transplant
Not Provided
Approximate Structure (In weeks)
Inpatient
Not Provided
Outpatient/Consults
Not Provided
Other (specify)
Not Provided
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
Not Provided
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Not Provided
< Back to Results